International Journal of Legal Medicine

, Volume 114, Issue 6, pp 352–356

One fatal and seven non-fatal cases of 4-methylthioamphetamine (4-MTA) intoxication: clinico-pathological findings

Authors

  • E. A. De Letter
    • Department of Forensic Medicine, Ghent University, J. Kluyskensstraat 29, 9000 Ghent, Belgium e-mail: Michel.Piette@rug.ac.be, Tel.: +32-9-2649291, Fax: +32-9-2649495
  • Vera A. E. Coopman
    • Toxicological Laboratory, Chemiphar NV, L. Bauwensstraat 4, 8200 Bruges, Belgium
  • Jan A. C. M. Cordonnier
    • Toxicological Laboratory, Chemiphar NV, L. Bauwensstraat 4, 8200 Bruges, Belgium
  • M. H. A. Piette
    • Department of Forensic Medicine, Ghent University, J. Kluyskensstraat 29, 9000 Ghent, Belgium e-mail: Michel.Piette@rug.ac.be, Tel.: +32-9-2649291, Fax: +32-9-2649495
Case report

DOI: 10.1007/s004140100204

Cite this article as:
De Letter, E., Coopman, V., Cordonnier, J. et al. Int J Leg Med (2001) 114: 352. doi:10.1007/s004140100204

Abstract

We present a case history involving one fatal and seven survived cases of intoxication with 4-methylthioamphetamine (4-MTA), also called para-methylthioamphetamine (p-MTA) or methylthioamphetamine (MTA), a relatively new amphetamine analogue. Two of the seven survivors required a 24-h-period of observation in hospital. This report proves once again that the new amphetamine designer drugs are not without danger, as is thought by many young people. In addition, individually different subjective reactions are described. Finally, the medico-legal implications of new, as yet unregistered drugs are discussed.

Keywords Drug abuse4-MTA4-MethylthioamphetamineAmphetaminesIntoxication

Copyright information

© Springer-Verlag Berlin Heidelberg 2001